Skip to content

Quantitative Chest CT-derived Fibrosis and Vascular Remodeling and Acute Exacerbation Risk in Mild Idiopathic Pulmonary Fibrosis.

Oct 2026 · Radiology · Vol 321 1, pp. e260703 · 1 citation · 29 references
Medicine

TL;DR

In mild IPF, fibrosis burden and vascular remodeling were associated with acute exacerbation risk, with venous and arterial remodeling mediating fibrosis effects, and higher small-artery volume fraction associated with reduced acute exacerbation risk.

Abstract

Background Acute exacerbations worsen outcomes in idiopathic pulmonary fibrosis (IPF), but the role of vascular remodeling remains unclear. Purpose To determine whether quantitative CT-derived vascular metrics are independently associated with acute exacerbations in mild IPF and whether arterial or venous remodeling mediates the effects of fibrosis burden. Materials and Methods In this retrospective cohort study, patients with mild IPF (forced vital capacity ≥ 80% and diffusing capacity for carbon monoxide ≥ 55%) underwent baseline volumetric high-spatial-resolution unenhanced chest CT between April 2011 and December 2021 at a single tertiary hospital. Fibrosis score (FS) and vascular metrics were assessed using deep learning-based software. The primary outcome was time to acute exacerbation; the secondary outcome was event-free survival for acute exacerbation, lung transplantation, and death (composite outcome). Multivariable Cox models were used to evaluate both outcomes, adjusting for age, smoking status, and pack-years. Mediation analysis was used to assess whether vascular remodeling mediated the association between FS and the outcomes. Results Among 313 patients (mean age, 66.4 years ± 7.1 [SD]; 245 male patients), 86 (27.5%) experienced acute exacerbation, two (0.6%) underwent lung transplantation, and 120 (38.3%) died during a median 6.3 years of follow-up. Higher FS was associated with a higher estimated risk of acute exacerbation (adjusted hazard ratio [aHR] range across models, 1.05-1.09; P value range, .001-.10) and of the composite outcome (aHR range, 1.08-1.20; all P ≤ .001). Venous dilatation (aHR, 7.93 [95% CI: 2.56, 24.59]) and venous diameter heterogeneity (aHR, 1.37 [95% CI: 1.16, 1.63]) were associated with increased acute exacerbation risk, whereas higher small-artery volume fraction was associated with reduced risk (aHR, 0.91 [95% CI: 0.86, 0.96]). FS effects on acute exacerbation were mediated by venous remodeling (57.1% mediation; P = .001) and by small-artery volume fraction (21.5%; P = .02). Conclusion In mild IPF, fibrosis burden and vascular remodeling were associated with acute exacerbation risk, with venous and arterial remodeling mediating fibrosis effects, and higher small-artery volume fraction associated with reduced acute exacerbation risk. © RSNA, 2026 Supplemental material is available for this article. See also the editorial by Iwasawa in this issue.

View source

Similar papers

Open access Sep 2026

Absolute and lung volume-normalized deep learning-derived pulmonary vascular measures in idiopathic pulmonary fibrosis: distinct clinical associations and the role of lung volume in prognosis

Introduction Idiopathic pulmonary fibrosis (IPF) has an unpredictable course and poor outcome, and lung function-based risk stratification remains incomplete. Whether absolute and lung volume-normalized deep learning-derived CT pulmonary vascular measurements show distinct associations with disease severity and mortali...

Gaetano Rea, Stefano Sanduzzi Zamparelli, Annalisa Mazzocca et al. · 0 citations
Open access Oct 2026

HRCT-assessed fibrosis burden predicts mortality better than pulmonary function decline in progressive pulmonary fibrosis

BACKGROUND AND AIM: Progressive pulmonary fibrosis (PPF) is a clinically significant phenotype observed across fibrotic interstitial lung diseases (ILDs), characterized by pulmonary functional decline, radiologic progression, and worsening symptoms. While declines in forced vital capacity (FVC) and diffusing capacity f...

Nilüfer Yiğit, Goksel Altinisik, H. Yavas et al. · 0 citations
Open access Sep 2026

Contemporary Fibrotic Interstitial Lung Disease Outcomes: A Multicentre National Cohort Study.

BACKGROUND AND OBJECTIVE This study determined contemporary transplant-free survival in fibrotic interstitial lung disease (ILD), identified baseline factors associated with death or transplant, and assessed performance of the ILD-GAP (Gender, Age, Physiology) index in a contemporary cohort. METHODS Patients with idi...

T. Pitre, C. Ryerson, S. Ong et al. · 0 citations
Open access Sep 2026

Trajectories of progressive pulmonary fibrosis and outcomes in connective tissue disease associated interstitial lung disease (CTD-ILD)

Regular pulmonary function monitoring and continuous assessment of PPF progression are essential for patients with CTD-ILD and disease-directed treatment may reduce the risk of PPF development.

Jeewon Lee, Ahran Kim, Kyuhwan Kim et al. · 0 citations
Open access Oct 2026

Quantitative CT features for COPD classification and GOLD spirometric severity assessment: a single-center model-development study

Background Chronic obstructive pulmonary disease (COPD) is diagnosed primarily by post-bronchodilator spirometry, but quantitative CT can characterize emphysema and visible-airway structural abnormalities that are not fully captured by airflow measurements alone. Because CT-derived emphysema and airway features have be...

Kai-Feng Du, Jia-Meng Gao, Ji Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.